Coronary Atherectomy Market Size, Share & Trends Analysis | Global | 2025-2032 | Includes: Laser, and Mechanical Atherectomy

Global Coronary Atherectomy Market Report, 2025 Edition

By iData Research - 45 pages - 5 charts, 30 figures

Executive Summary

The global coronary atherectomy market was valued at nearly $374 million in 2025 and is expected to grow at a CAGR of 4.1% to reach approximately $496 million over the forecast period. Growth remains moderate as atherectomy continues to serve a targeted role in complex coronary interventions.
This report follows the same methodology outlined in the reference document, combining unit sales, average selling prices and procedural data to model market size and forecast trends .
Coronary atherectomy devices are primarily used in cases involving heavily calcified or fibrotic lesions where standard balloon angioplasty or stent delivery is insufficient. These devices support lesion preparation and improve procedural success in challenging cases.
Although the adoption of drug-eluting stents has reduced the reliance on extensive lesion preparation, the increasing number of complex interventions continues to support steady demand for atherectomy technologies globally.

Market Overview

The global coronary atherectomy market includes devices designed to remove or modify atherosclerotic plaque within coronary arteries prior to or during interventional procedures. These devices are typically used in cases where lesions are too calcified or rigid for standard balloon or stent-based approaches.
The market is segmented into mechanical atherectomy and laser atherectomy, each offering different approaches to plaque modification. Mechanical systems use rotational or orbital motion to break down plaque, while laser systems use energy to vaporize material within the vessel.
Atherectomy devices are not used in all coronary interventions and are generally reserved for complex cases. As a result, market growth is closely tied to the prevalence of difficult lesions and the willingness of physicians to adopt advanced procedural techniques.
The broader interventional cardiology environment continues to influence this market. While procedural volumes remain stable, the increasing complexity of cases, combined with improved imaging and diagnostic capabilities, is supporting incremental growth in atherectomy usage.

Market Drivers

One of the primary drivers of the coronary atherectomy market is the increasing volume of angiographic and interventional procedures. As more patients undergo coronary interventions, the number of cases involving complex lesions also rises, creating greater demand for specialized tools such as atherectomy devices.
Technological innovation is another important growth factor. While many recent advancements have originated in the peripheral atherectomy market, several of these technologies are being adapted for coronary applications. These next-generation devices are expected to improve ease of use, enhance safety and increase procedural success rates.
The growing prevalence of difficult lesions also supports market expansion. Calcified and fibrotic lesions present significant challenges during interventions, often preventing successful balloon expansion or stent deployment. In these cases, atherectomy devices are used to modify the lesion and enable treatment.
Advancements in imaging technologies further support the use of atherectomy. Improved visualization of lesion characteristics allows physicians to better identify cases where atherectomy may be beneficial, leading to more targeted and effective use of these devices.

Market Limiters

A major limitation in the coronary atherectomy market is the continued effectiveness and widespread adoption of drug-eluting stents. These devices reduce the need for extensive lesion preparation by preventing restenosis, which decreases the reliance on atherectomy in many procedures.
The shortage of trained healthcare professionals also limits market growth. Atherectomy procedures require specialized skills and experience, and the global shortage of skilled physicians and support staff can restrict procedural volumes.
Cost considerations represent another significant barrier. Atherectomy devices increase the overall cost of interventional procedures, and in many regions, these costs are not fully reimbursed. This limits their use to cases where they are considered absolutely necessary.
In addition, the optional nature of atherectomy use creates variability in adoption. Physician preference and institutional protocols play a large role in determining whether these devices are used, leading to inconsistent utilization across different markets.
Finally, the complexity of atherectomy procedures can deter adoption. Physicians may prefer alternative approaches when possible, particularly in healthcare systems where efficiency and procedure time are key considerations.

Market Coverage and Data Scope

Quantitative Coverage
Market size, market shares, market forecasts, growth rates, units sold and average selling prices.
Qualitative Coverage
Market trends, market limiters, competitive analysis, mergers and acquisitions, company profiles, product portfolios and technology developments.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.

Markets Covered and Segmentation

The Global Coronary Atherectomy Market is segmented into:
Device Type
Mechanical Atherectomy
Laser Atherectomy
Each segment is analyzed by unit volume, average selling price and total market value. Forecasts and historical data provide insight into long-term trends and segment performance.
Mechanical atherectomy devices represent the largest share of the market due to their broader adoption and established clinical use. Laser atherectomy systems occupy a smaller niche but continue to provide value in specific clinical scenarios.

Competitive Analysis

Boston Scientific held the leading position in the coronary atherectomy market in 2025, primarily due to its strength in the mechanical atherectomy segment. The company’s established product portfolio and strong relationships with physicians have supported its leadership position. However, its market share has declined slightly in recent years as competition has increased.
Abbott ranked as the second-largest competitor in the market. The company’s Diamondback 360® orbital atherectomy system remains a key product within its portfolio. Abbott’s broad presence across interventional cardiology allows it to maintain a stable position, although significant market share expansion is not expected.
Philips is also a notable participant in the coronary atherectomy market. The company offers the Neximer and CVX-300 Excimer laser systems, which support its presence in the laser atherectomy segment. Philips is expected to gain modest market share as it continues to invest in product development and portfolio expansion.
The competitive landscape is relatively concentrated, with a small number of companies dominating the market. Competition is driven by product performance, clinical outcomes and physician familiarity rather than rapid technological disruption.

Technology and Practice Trends

There is increasing focus on improving the usability and safety of atherectomy devices. Manufacturers are developing systems that are easier to operate and provide more consistent results across different types of lesions.
Another key trend is the integration of atherectomy with advanced imaging technologies. As imaging capabilities improve, physicians can better assess lesion characteristics and determine when atherectomy is appropriate.
The adaptation of technologies from the peripheral atherectomy market is also influencing development. These innovations are being refined for coronary use and are expected to enhance performance and expand clinical applications.
At the same time, adoption remains selective. Atherectomy is primarily used in complex cases rather than routine procedures, which limits overall market growth but ensures continued relevance in specialized applications.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Deliverables

45 pages of detailed narrative analysis, tables and forecasts.
5 charts and 20 figures illustrating market segmentation and performance metrics.

Methodology Appendix and Acronym Glossary
explaining all data definitions and modeling assumptions.
Licensing options include single-user, site and enterprise.

Why This Report

What are the key drivers and limitations shaping the coronary atherectomy market?
How is the adoption of drug-eluting stents affecting demand for atherectomy devices?
Which companies lead the market and how are they positioned competitively?
What role do imaging technologies play in guiding atherectomy use?
How are cost pressures and reimbursement challenges influencing adoption?
What are the primary risks and barriers to growth across global markets?
Which regions offer the most potential for expansion?
The Global Coronary Atherectomy Market Report from iData Research answers these questions through detailed procedure-based modeling, competitive benchmarking and pricing analysis.
Use this report to understand market dynamics, evaluate opportunities and develop informed strategies within the interventional cardiology device market.

About iData Research

iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC. Show more